Search clinical trials for: LightPath® Imaging System and 68Ga-RM2

Total 3760 results

Lightpoint Medical Limited

Not yet recruiting

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Breast Cancer

United Kingdom
Lightpoint Medical Limited
European Commission

Unknown

The LightPath® Breast Cancer Study

Breast Cancer

Poland, United Kingdom
Huashan Hospital

Recruiting

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
King's College London

Recruiting

CLI and FAR for Intraoperative Margin Assessment (CLI-FAR)

Breast Cancer Female

United Kingdom
Memorial Sloan Kettering Cancer Center

Completed

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Prostate Cancer

United States
Andrei Iagaru

Completed

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Prostate Adenocarcinoma

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NOTA-RM26 PET/CT in Glioma Patients

Glioma

China
Peking Union Medical College Hospital

Recruiting

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Breast Cancer | Prostate Cancer | Brain Tumor | PET/CT Imaging

China
Life Molecular Imaging SA

Terminated

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Prostate Cancer

Austria, Finland
Peking University First Hospital

Recruiting

68Ga-P3 PET/CT Imaging in Malignancy

Neoplasms

China
IRCCS San Raffaele

Completed

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

Prostate Cancer

Italy
Peking University First Hospital

Recruiting

68Ga-N188 PET/CT Imaging in Malignancy

Neoplasms

China
University Hospital, Bordeaux

Recruiting

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging (PROSTATEP)

Prostate Cancer

France
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer

France
Qifu Li
The Affiliated Hospital Of Southwest Medical University

Completed

68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism

Primary Aldosteronism

China
Karolinska University Hospital
Uppsala University; Stockholm South General Hospital

Recruiting

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

Cancer

Sweden
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer

Bladder Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

Prostate Carcinoma

United States
Peking Union Medical College Hospital
Stanford University

Unknown

68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Huashan Hospital

Recruiting

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Kidney Cancer | Positron Emission Tomography | Lymphomas

China
Advanced Accelerator Applications

Completed

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) (PROfind)

Prostate Cancer Metastatic

United States
Andrei Iagaru

Completed

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage IV Prostate Adenocarcinoma

United States
Children's Hospital of Philadelphia
EOS imaging Inc.

Completed

Adolescent Idiopathic Scoliosis (AIS) Patient Positioning in EOS System®

Adolescent Idiopathic Scoliosis

United States
Catholic University of the Sacred Heart

Completed

Study of Effectiveness of rMV (Repeated Muscle Vibration) in Knee Osteoarthritis

Knee Osteoarthritis

Italy
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients

Breast Tumor

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

Prostate Cancer

China
Lightpoint Medical Limited
Semmelweis University

Withdrawn

Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery (CLIO)

Gastric Cancer | Pancreatic Cancer | Bile Duct Cancer | Duodenal Cancer

Hungary
Turku University Hospital
University of Turku

Unknown

PET-imaging of Unruptured Intracranial Aneurysm Inflammation (PET-IA)

Inflammation | Cerebral Aneurysm | Intracranial Aneurysm

Finland
Andrei Iagaru
General Electric

Completed

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Prostate Cancer

United States
University Hospital, Basel, Switzerland

Completed

Melanoma Detection in Switzerland With VECTRA (MELVEC)

Melanoma (Skin)

Switzerland
The First Affiliated Hospital of Xiamen University

Recruiting

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors

Solid Tumor | Tumor | Positron-Emission Tomography

China
University of California, San Francisco

Terminated

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Thyroid Gland Carcinoma

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors

China
Wuhan Union Hospital, China

Recruiting

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Neuroendocrine Tumors | Osteomalacia | PET / CT | PET / MR

China
Methodist Health System

Completed

Evaluation of Safety and Efficacy of NvisionVLE® Imaging Low Profile System in Patients With Bile Duct Disease

Bile Duct Diseases

United States
Turku University Hospital

Completed

Imaging of Joint Replacement Complications by PET/CT (Propeli)

Infection of Total Hip Joint Prosthesis | Adverse Reactions to Metal Debris | Mechanical Loosening of Prosthetic Joint

Finland
Malini Madhavan

Recruiting

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation

Atrial Fibrillation | Arrhythmia

United States
Colchester Hospital University NHS Foundation Trust

Completed

Juxta-CuresTM Versus Bandaging for Venous Ulcers (Juxta-Cures)

Venous Ulcer

United Kingdom
Weill Medical College of Cornell University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Evaluation of PSMA Antagonist Produced by Two Different Methods

Metastatic Prostate Adenocarcinoma

United States
University Hospital, Bordeaux

Completed

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation (GALTEP)

Neuroendocrine Tumors

France
University of the State of Santa Catarina
Larissa Sinhorim

Recruiting

Fascial Tissue Response To Manual Therapy: Implications In Long Covid Rehabilitation

COVID-19

Brazil
Assistance Publique Hopitaux De Marseille

Completed

Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin (EXPRET)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

France
Peter MacCallum Cancer Centre, Australia

Recruiting

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary (FAPI-CUP)

Cancer of Unknown Primary Site

Australia
Institut Curie

Not yet recruiting

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT) (FAP-IT)

Triple Negative Breast Cancer
Maimonides Medical Center

Completed

Fluorescent Evaluation of Colorectal Anastamoses

Rectal Neoplasms | Diverticulitis | Colon Neoplasms

United States
Novartis Pharmaceuticals

Recruiting

A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.

Metastatic Castration-resistant Prostate Cancer (mCRPC)

France
Thomas Hope
Clovis Oncology, Inc.

Recruiting

Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

Myocardial Fibrosis | Pulmonary Fibrosis | Liver Fibrosis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Recurrent Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8
NanOlogy, LLC
US Biotest, Inc.

Terminated

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Ovarian Carcinoma

United States
Johns Hopkins All Children's Hospital

Terminated

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Central Nervous System Tumors

United States

Search clinical trials for: LightPath® Imaging System and 68Ga-RM2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations